Admission Date:  [**2154-9-13**]              Discharge Date:   [**2154-10-11**]  Date of Birth:  [**2106-8-11**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Bactrim / Epinephrine / Percocet / Codeine / Latex  Attending:[**First Name3 (LF) 165**] Chief Complaint: SSCP  Major Surgical or Invasive Procedure: [**9-14**] RVAD insertion/ECMO decannulation   History of Present Illness: 48 yo F presented to [**Location (un) **] ED [**9-13**] with new onset SSCP, + STEMI.
She was taken emergently to the cath lab, where 3 bare metal stents were placed in a totally occluded RCA.
She was placed on ECMO, and then was taken to the OR with vascular surgery for repair of her Left CFA, CFV, and EIA at the site of the previous IABP.
On [**9-14**] she was taken to the operating room where she underwent placement of and RVAD and removal of ECMO.
She was transferred to the SICU on epinephrine, milrinone, levophed and propofol as well as Nitric oxide.
Cultures remained negative, she was placed on broad antibiotic coverage.
She remained intubated and paralyzed, with likely ARDS.
She was started on tube feeds.
Vascular continued to follow her for her groin incisions, which eventually required VAC dressing.
Her sternal wound developed purulent draiange, and the wound was opened and a vac dressing was applied there as well.
She remained on vanco, zosyn and flagyl.
There as no bleed or infarct on head CT. She was seen by optho for conjunctivitis and placed on erythromycin ointment.
Her respiratory status improved and her sedation was weaned.
Her zosyn was changed to meropenum given the continued fevers, as well as fluconazole for some yeast growth from her wounds.
She remained febrile despite antibiotic change, however her white count began to improve.
She was taken to the cath lab on [**10-7**] for placement of a PA cath in preparation for RVAD weaning.
Fevers continued, she remained on vanco, fluc, and ceftaz was started on [**10-8**].
She was started on a protonix drip.
Her heparin was stopped and she was started on Dextran.
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Insulin Regular Human 100 unit/mL Solution Sig: One (1) Injection INFUSION (continuous infusion).
Acetaminophen 160 mg/5 mL Solution Sig: [**11-19**]  PO Q4-6H (every 4 to 6 hours) as needed for fever.
Polyvinyl Alcohol 1.4 % Drops Sig: 1-2 Drops Ophthalmic  Q8H (every 8 hours) as needed.
Albuterol-Ipratropium 103-18 mcg/Actuation Aerosol Sig: Four (4) Puff Inhalation Q4H (every 4 hours).
Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical  QID (4 times a day) as needed.
Miconazole Nitrate 2 % Cream Sig: One (1) Appl Topical  [**Hospital1 **] (2 times a day) as needed.
Potassium Chloride 20 mEq / 50 ml SW IV PRN K<4.4 and CR<2.0  ** Concentrated KCL must be given via central line only ** 13.
Erythromycin 5 mg/g Ointment Sig: One (1)  Ophthalmic  [**Hospital1 **] (2 times a day).
Ibuprofen 100 mg/5 mL Suspension Sig: One (1)  PO Q8H (every 8 hours) as needed for T>102.
Pantoprazole 40 mg Recon Soln Sig: Eight (8) Recon Soln Intravenous  INFUSION (continuous infusion).
Furosemide 80 mg IV BID 17.
Metoclopramide 10 mg IV Q6H:PRN nausea/vomiting 18.
Vancomycin HCl 1000 mg IV Q 24H 19.
Metoprolol 10 mg IV Q4H 20.
CeftazIDIME 1 gm IV Q12H 22.
HydrALAZINE HCl 20 mg IV Q6H:PRN sbp>160 23.
Morphine Sulfate 1-5 mg IV Q4H:PRN 24.
Lorazepam 0.5-1 mg IV Q4H:PRN 25.
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: Thirty Five (35) units Subcutaneous BREAKFAST (Breakfast): 35 units QAM 25 units QPM.
Discharge Disposition: Extended Care  Facility: [**Hospital1 2025**]  Discharge Diagnosis: Acute MI, Cardiogenic shock, RV failure, Recent RCA stents Ebsteins Anomaly s/p Left THR 3 weeks ago secondary to AVN ([**2154-8-8**]) Inferior STEMI lipids LBP hypothyroid thallesemia minor DM2 PUD GERD Glaucoma s/p multiple surgeries Obesity tobacco abuse h/o junctional rhythm depression   Discharge Condition: Stable                                [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 173**]  Completed by:[**2154-10-11**
